Forat Lutfi

552 total citations
49 papers, 257 citations indexed

About

Forat Lutfi is a scholar working on Oncology, Hematology and Immunology. According to data from OpenAlex, Forat Lutfi has authored 49 papers receiving a total of 257 indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Oncology, 17 papers in Hematology and 10 papers in Immunology. Recurrent topics in Forat Lutfi's work include CAR-T cell therapy research (24 papers), Hematopoietic Stem Cell Transplantation (9 papers) and COVID-19 Clinical Research Studies (5 papers). Forat Lutfi is often cited by papers focused on CAR-T cell therapy research (24 papers), Hematopoietic Stem Cell Transplantation (9 papers) and COVID-19 Clinical Research Studies (5 papers). Forat Lutfi collaborates with scholars based in United States, India and Jordan. Forat Lutfi's co-authors include Aaron P. Rapoport, Saurabh Dahiya, Nancy M. Hardy, Jean A. Yared, Mehmet H. Kocoglu, Ali Bukhari, Sarah B. Sunshine, Natalie Gahres, Noa G. Holtzman and Kathleen Ruehle and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Frontiers in Immunology.

In The Last Decade

Forat Lutfi

37 papers receiving 257 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Forat Lutfi United States 10 194 54 44 41 39 49 257
Marta García‐Recio Spain 6 245 1.3× 39 0.7× 71 1.6× 33 0.8× 46 1.2× 12 294
Núria Martínez‐Cibrián Spain 9 189 1.0× 63 1.2× 46 1.0× 66 1.6× 44 1.1× 23 286
Aishat Olaide Afuye United States 4 250 1.3× 39 0.7× 79 1.8× 27 0.7× 46 1.2× 4 275
Xiaolu Long China 9 133 0.7× 34 0.6× 31 0.7× 38 0.9× 75 1.9× 22 233
David M. Cordas dos Santos Germany 8 251 1.3× 45 0.8× 34 0.8× 49 1.2× 82 2.1× 16 304
Uri Greenbaum Israel 9 117 0.6× 55 1.0× 23 0.5× 37 0.9× 37 0.9× 26 232
Mari Lynne Silverberg Thailand 2 227 1.2× 33 0.6× 71 1.6× 22 0.5× 43 1.1× 2 246
Felix Korell Germany 10 258 1.3× 78 1.4× 60 1.4× 22 0.5× 78 2.0× 22 329
Agrima Mian United States 8 151 0.8× 20 0.4× 33 0.8× 22 0.5× 47 1.2× 36 248

Countries citing papers authored by Forat Lutfi

Since Specialization
Citations

This map shows the geographic impact of Forat Lutfi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Forat Lutfi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Forat Lutfi more than expected).

Fields of papers citing papers by Forat Lutfi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Forat Lutfi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Forat Lutfi. The network helps show where Forat Lutfi may publish in the future.

Co-authorship network of co-authors of Forat Lutfi

This figure shows the co-authorship network connecting the top 25 collaborators of Forat Lutfi. A scholar is included among the top collaborators of Forat Lutfi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Forat Lutfi. Forat Lutfi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Shahzad, Moazzam, Muhammad Atif Khan, Muhammad Kashif Amin, et al.. (2025). Impact of Systemic Antibiotics Use on Outcomes after Allogeneic Hematopoietic Stem Cell Transplantation. Transplantation and Cellular Therapy. 31(2). S510–S510. 1 indexed citations
2.
Shahzad, Moazzam, Muhammad Kashif Amin, Zouina Sarfraz, et al.. (2024). Outcomes with chimeric antigen receptor T-cell therapy in Rheumatological disorders: A systematic review. Transplant Immunology. 87. 102137–102137. 4 indexed citations
3.
Mushtaq, Muhammad Umair, Moazzam Shahzad, Muhammad Kashif Amin, et al.. (2024). Outcomes with HLA-matched unrelated donor versus haploidentical hematopoietic cell transplantation. Leukemia & lymphoma. 65(4). 493–502. 2 indexed citations
4.
Jindal, Vishal, et al.. (2024). Romiplostim for chemotherapy induced thrombocytopenia in solid tumors: A meta-analysis.. Journal of Clinical Oncology. 42(16_suppl). e24137–e24137.
5.
Филиппов, Е. В., et al.. (2024). The current socioeconomic and regulatory landscape of immune effector cell therapies. Frontiers in Medicine. 11. 1462307–1462307. 4 indexed citations
6.
Lutfi, Forat, et al.. (2023). Outcomes of Patients with Relapsed/Refractory Multiple Myeloma Who Received at Least 2 BCMA-Directed Therapies. Blood. 142(Supplement 1). 1969–1969. 1 indexed citations
7.
Shahzad, Moazzam, Andrea Nguyen, Muhammad Salman Faisal, et al.. (2023). Outcomes with chimeric antigen receptor t-cell therapy in relapsed or refractory acute myeloid leukemia: a systematic review and meta-analysis. Frontiers in Immunology. 14. 1152457–1152457. 24 indexed citations
8.
Lutfi, Forat, et al.. (2023). Exploring the High-Grade and Refractory Neurotoxicity of Teclistamab: An Underreported Entity. Cureus. 15(11). e49192–e49192. 2 indexed citations
9.
Mushtaq, Muhammad Umair, Rajat Bansal, Forat Lutfi, et al.. (2023). Risk Factors and Outcomes for Patients with Persistent Cytopenia Following Administration of CD19 CAR-T Cell Therapy in B Cell Lymphoma. Transplantation and Cellular Therapy. 29(2). S187–S188. 1 indexed citations
10.
Fischer, Andrew M., Forat Lutfi, Djordje Atanackovic, et al.. (2022). Ocular adverse events associated with chimeric antigen receptor T-cell therapy: a case series and review. British Journal of Ophthalmology. 107(7). 901–905. 11 indexed citations
11.
Atanackovic, Djordje, Forat Lutfi, Diego de Miguel‐Pérez, et al.. (2021). Deep dissection of the antiviral immune profile of patients with COVID-19. Communications Biology. 4(1). 1389–1389. 6 indexed citations
12.
Atanackovic, Djordje, Tim Luetkens, Nancy M. Hardy, et al.. (2021). Anti-SARS-CoV-2 Immune Responses in Patients Receiving an Allogeneic Stem Cell or Organ Transplant. Vaccines. 9(7). 737–737. 2 indexed citations
13.
Lutfi, Forat, Long Wu, Sarah B. Sunshine, & Xuefang Cao. (2021). Targeting the CD27-CD70 Pathway to Improve Outcomes in Both Checkpoint Immunotherapy and Allogeneic Hematopoietic Cell Transplantation. Frontiers in Immunology. 12. 715909–715909. 15 indexed citations
14.
Holtzman, Noa G., Hao Xie, Søren M. Bentzen, et al.. (2020). Immune effector cell–associated neurotoxicity syndrome after chimeric antigen receptor T-cell therapy for lymphoma: predictive biomarkers and clinical outcomes. Neuro-Oncology. 23(1). 112–121. 71 indexed citations
15.
Lutfi, Forat, Rohit Bishnoi, Shuyao Zhang, et al.. (2020). Bleeding and Thrombotic Risk in Low Dose Heparin Infusion as Compared to Standard Dose Heparin Infusion. Cureus. 12(5). e8339–e8339. 2 indexed citations
16.
Lutfi, Forat, et al.. (2020). Agranulocytosis Following COVID-19 Recovery. Cureus. 12(7). e9463–e9463. 6 indexed citations
17.
Lutfi, Forat, Noa G. Holtzman, Ali Bukhari, et al.. (2020). Chimeric antigen receptor T‐cell therapy after allogeneic stem cell transplant for relapsed/refractory large B‐cell lymphoma. British Journal of Haematology. 192(1). 212–216. 15 indexed citations
18.
Lutfi, Forat, William Paul Skelton, Yu Wang, et al.. (2019). Clinical predictors of delayed engraftment in autologous hematopoietic cell transplant recipients. Hematology/Oncology and Stem Cell Therapy. 13(1). 23–31. 9 indexed citations
19.
Lutfi, Forat, et al.. (2018). Hemophagocytic lymphohistiocytosis (HLH) presenting as fever of unknown origin and acute liver failure. IDCases. 14. e00413–e00413. 5 indexed citations
20.
Lutfi, Forat, William Paul Skelton, Nosha Farhadfar, et al.. (2017). Poor Graft Function Following Autologous Stem Cell Transplant (ASCT): A Retrospective Analysis over Two Decades at a Transplant Center. Blood. 130. 4529–4529. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Marta García‐Recio Breakdown of academic impact, for papers by Núria Martínez‐Cibrián Breakdown of academic impact, for papers by Aishat Olaide Afuye Breakdown of academic impact, for papers by Xiaolu Long Breakdown of academic impact, for papers by David M. Cordas dos Santos Breakdown of academic impact, for papers by Uri Greenbaum Breakdown of academic impact, for papers by Mari Lynne Silverberg Breakdown of academic impact, for papers by Felix Korell Breakdown of academic impact, for papers by Agrima Mian
Rankless by CCL
2026